Emily Charrier
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
- T-cell and B-cell Immunology
- Immune cells in cancer
- Reproductive System and Pregnancy
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
Papers in
- Immunology 21
- Immune Cell Function and Interaction 18
- Immunotherapy and Immune Responses 7
- T-cell and B-cell Immunology 7
- Immune Response and Inflammation 3
-
- Hematopoietic Stem Cell Transplantation 5
- Co-authors
- Thierry Walzer (10 shared papers)Sébastien Viel (8 shared papers)Jacques Bienvenu (5 shared papers)Jacqueline Marvel (2 shared papers)Antoine Marçais (5 shared papers)Uzma Ayesha Hasan (2 shared papers)Thomas Anderson Henry (3 shared papers)Immo Prinz (1 shared paper)
- Journals
- The Journal of Immunology (5 papers)Vaccines (2 papers)Molecular Therapy — Methods & Clinical Development (2 papers)Immunological Investigations (1 paper)Bone Marrow Transplantation (1 paper)
- Partner nations
- FranceCanadaSwitzerland
In The Last Decade
Emily Charrier
27 papers receiving 1.5k citations
Emily Charrier's Hit Papers
Peers
Comparison fields: 5 of 78
- Immunology 1.1k
- Hematology 153
- Oncology 305
- Cancer Research 94
- Surgery 199
Countries citing papers authored by Emily Charrier
This map shows the geographic impact of Emily Charrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Charrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Charrier more than expected).
Fields of papers citing papers by Emily Charrier
This network shows the impact of papers produced by Emily Charrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Charrier. The network helps show where Emily Charrier may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Charrier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway Hit paper breakdown → | 2016 | 550 |
| 2 | 2014 | 473 | |
| 3 | 2016 | 99 | |
| 4 | 2016 | 61 | |
| 5 | 2010 | 51 | |
| 6 | 2013 | 39 | |
| 7 | 2012 | 38 | |
| 8 | 2011 | 24 | |
| 9 | 2012 | 24 | |
| 10 | 2020 | 17 | |
| 11 | 2012 | 14 | |
| 12 | 2018 | 14 | |
| 13 | 2010 | 13 | |
| 14 | 2012 | 13 | |
| 15 | 2021 | 12 | |
| 16 | 2021 | 9 | |
| 17 | 2022 | 8 | |
| 18 | 2014 | 7 | |
| 19 | 2018 | 5 | |
| 20 | 2021 | 5 |
About Emily Charrier
Emily Charrier is a scholar working on Immunology, Hematology, Oncology, Infectious Diseases and Molecular Biology, having authored 28 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (18 papers), Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (7 papers), Hematopoietic Stem Cell Transplantation (5 papers), CAR-T cell therapy research (3 papers), Immune Response and Inflammation (3 papers), CRISPR and Genetic Engineering (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Immunology (1.1k citations), Hematology (153 citations), Oncology (305 citations), Cancer Research (94 citations) and Surgery (199 citations). Emily Charrier has collaborated with scholars based in France, Canada and Switzerland. Frequent co-authors include Thierry Walzer, Sébastien Viel, Jacques Bienvenu, Jacqueline Marvel, Antoine Marçais, Uzma Ayesha Hasan, Thomas Anderson Henry, Immo Prinz, David K. Finlay and Laurent Buffat. Their work appears in journals such as The Journal of Immunology, Vaccines, Molecular Therapy — Methods & Clinical Development, Immunological Investigations and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.